Author response to ‘Comment on “Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab bevacizumab alone in women with newly diagnosed advanced ovarian cancer” (. 2021 Sep 30;13:17588359211049639)’

Author response to ‘Comment on “Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab bevacizumab alone in women with newly diagnosed advanced ovarian cancer” (. 2021 Sep 30;13:17588359211049639)’

Bibliographic Details
Main Authors: Robert Hettle, Charles McCrea
Format: Article
Language:English
Published: SAGE Publishing 2023-04-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359231168519

Similar Items

Similar Items